Atopic Dermatitis (Eczema) Clinical Trials near Dallas, TX
13 studies for Atopic Dermatitis (Eczema) are recruiting at 21 sites within 50 miles of Dallas, Texas, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Atopic Dermatitis (Eczema) trials in the US or all trials near Dallas.
Recruiting now
Atopic Dermatitis (Eczema) studies enrolling near Dallas
- A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
NCT06389136
- Phase 3
- Ages 18 to 63 years
- Sex: All
Nearest sites: Dermatology Treatment and Research Center /ID# 265812 (Dallas, TX); Modern Research Associates /ID# 263852 (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
NCT05995964
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest sites: Dermatology Treatment and Research Center (Dallas, TX); North Texas Center for Clinical Research (Frisco, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993
- Phase 2
- Ages 18 to 100 years
- Sex: All
Nearest sites: Novartis Investigative Site (Dallas, TX); Novartis Investigative Site (Arlington, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
NCT06988605
- Observational
- Ages 12 years and older
- Sex: All
Nearest sites: Galderma Investigational Site 8238 (Dallas, TX); Galderma Investigational Site 7088 (Grapevine, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
NCT07003425
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest sites: Investigational Site (Dallas, TX); Investigational Site (Frisco, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
NCT06982352
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: Clinical Investigations of Texas (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803
- Observational
- Ages 12 years and older
- Sex: All
Nearest site: Reveal Research Institute - Dallas- Site Number : 8400012 (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07643766
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: Enveda Investigative Site (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
NCT07765888
- Phase 3
- Ages 12 years and older
- Sex: All
Nearest site: Derm Texas (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
NCT07355075
- Phase 2/3
- Ages 18 to 80 years
- Sex: All
Nearest site: ALS Global (Irving, TX)
- Distance to nearest recruiting site
- ~9 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
NCT06461897
- Phase 3
- Ages 2 to 11 years
- Sex: All
Nearest sites: Arlington Research Center, Inc /ID# 266330 (Arlington, TX); Prime Clinical Research - Mansfield - East Broad Street /ID# 268042 (Mansfield, TX)
- Distance to nearest recruiting site
- ~18 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07298395
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Enveda Investigative Site (Arlington, TX)
- Distance to nearest recruiting site
- ~18 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
NCT07037901
- Phase 2
- Ages 18 to 74 years
- Sex: All
Nearest site: Inmagene Site 8 (Southlake, TX)
- Distance to nearest recruiting site
- ~22 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Atopic Dermatitis (Eczema) clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.